Beam Tx (BEAM) Narx-foyda koeffitsiyenti

Beam Therapeutics Inc (BEAM) korporativ emblemasi va logotipi

Genetik patologiyalarni davolashdagi patent monopoliyasi Beam Therapeutics Inc. (BEAM) kompaniyasini barqaror daromadlar oqimi bilan ta'minlaydi, bu esa kompaniyaning taxminiy P/E ko'rsatkichi bilan quvvatlanadi. Pfizer bilan hamkorlik aniq terapiyalarning ishlab chiqilishini tezlashtiradi, AQSh va Yevropa Ittifoqidagi neytral geosiyosiy muhit esa biznes barqarorligini ta'minlaydi. Joriy ko'rsatkich -22.40 darajasida bo'lib, bu aksiya narxini emitentning haqiqiy daromadlari bilan ob'ektiv taqqoslash imkonini beradi.

Beam Tx (BEAM) - Narx-foyda koeffitsiyenti 04.07.2022dan 15.11.2026gacha

Beam Therapeutics Inc (BEAM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Beam Therapeutics - BEAM
Beam Therapeutics yetakchi tovari

P/E koeffitsiyenti biznesning bozor qiymatini uning sof foydasi bilan solishtiradi, bu esa investorlarga aktivning haddan tashqari qimmat baholanganlik darajasini aniqlash va investitsiyaning qoplanish muddatini hisoblash imkonini beradi. Beam Therapeutics Inc. (BEAM) kompaniyasining choraklik P/E koeffitsiyentini tahlil qilish orqali investor texnologik milliyparvarlik va patent nizolari xavflari Beam Therapeutics Inc. (BEAM) kapitalizatsiyasiga qanday ta'sir qilishini ko'rishi mumkin, bu esa ushbu biofarmatsevtika emitentining fundamental barqarorligini tasdiqlash uchun juda muhimdir.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Sarepta Therapeutics, Inc. (SRPT) - P/E multiplikatori|TWST (twistbioscience.com) - P/E multiplikatori|10x Genomics, Inc. (TXG) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NTLA (Intellia Therapeutics, Inc.)|STOK - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati biolifesolutions.com BLFS|Biznesning o‘zini qoplash muddati Wave Life Sciences Corp (WVE)|MAZE - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati SION (Sionna Therapeutics Inc)|PRME: P/E multiplikatori|Taysha - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati uniQure NV|Narx-foyda multiplikatori MGTX (MeiraGTx PLC)|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati